Last10K.com

Galapagos Nv (GLPG) SEC Filing 20-F Annual report for the fiscal year ending Tuesday, December 31, 2019

SEC Filings

GLPG Valuations

Intrinsic Value
Financial Stability
Financial Ratios
Insider Trades
Manager Portfolios
Notifications

GLPG Annual Reports

    20-F Annual Report March 2022
    20-F Annual Report March 2021
  • 20-F Annual Report March 2020
    • 20-F Annual Report March 2019
    20-F Annual Report March 2018
    20-F Annual Report March 2017
    20-F Annual Report March 2016

GLPG Corporate News

Galapagos Nv

HISTORY TOOLS
CIK: 1421876 Ticker: GLPG

View differences made from one year to another to evaluate Galapagos Nv's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Galapagos Nv.

Continue

Assess how Galapagos Nv's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Galapagos Nv's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Statement Of Cash Flows
Consolidated Statement Of Cash Flows, Current Financial Investments
Consolidated Statement Of Changes In Equity
Consolidated Statement Of Comprehensive Income/Loss
Consolidated Statement Of Financial Position
Consolidated Statement Of Operations
Auditor's Remuneration
Auditor's Remuneration (Details)
Cash And Cash Equivalents
Cash And Cash Equivalents (Details)
Cash And Cash Equivalents (Tables)
Cash And Cash Equivalents - Narrative (Details)
Consolidated Companies As Of December 31, 2019
Consolidated Companies As Of December 31, 2019 (Details)
Consolidated Companies As Of December 31, 2019 (Tables)
Contingent Assets And Liabilities
Contingent Assets And Liabilities (Details)
Critical Accounting Judgments And Key Sources Of Estimation Uncertainty
Critical Accounting Judgments And Key Sources Of Estimation Uncertainty - Ifrs 15 ??? Revenue Recognition Gilead (Details)
Current Financial Investments
Current Financial Investments (Details)
Deferred Income
Deferred Income (Details)
Deferred Income (Tables)
Deferred Income - Movement In The Non-Current And Current Deferred Income (Details)
Deferred Tax
Deferred Tax (Tables)
Deferred Tax - Narrative (Details)
Deferred Tax - Summary Of Deferred Tax Assets And Liabilities (Details)
Events After Balance Sheet Date
Events After Balance Sheet Date (Details)
Fair Value Re-Measurement Of Share Subscription Agreement And Warrants Granted To Gilead
Fair Value Re-Measurement Of Share Subscription Agreement And Warrants Granted To Gilead (Tables)
Fair Value Re-Measurement Of Share Subscription Agreement And Warrants Granted To Gilead - Financial Assets (Details)
Financial Risk Management
Financial Risk Management (Tables)
Financial Risk Management - Aging Of Debtors (Details)
Financial Risk Management - Financial Risk Factors (Details)
Financial Risk Management - Interest Rate Risk And Foreign Exchange Risk (Details)
General Information
General Information (Details)
Income Taxes
Income Taxes (Tables)
Income Taxes - Narrative (Details)
Income Taxes - Schedule Of Tax Liabilities (Details)
Income Taxes - Summary Of Income Tax Recognized (Details)
Income Taxes - Summary Of Income Tax Reconciliation (Details)
Income/Loss (-) Per Share
Income/Loss (-) Per Share (Details)
Income/Loss (-) Per Share (Tables)
Intangible Assets
Intangible Assets (Details)
Intangible Assets (Tables)
Lease Liabilities
Lease Liabilities (Details)
Lease Liabilities (Tables)
Off-Balance Sheet Arrangements
Off-Balance Sheet Arrangements (Details)
Off-Balance Sheet Arrangements (Tables)
Operating Cash Flow
Operating Cash Flow (Details)
Operating Cash Flow (Tables)
Operating Costs
Operating Costs (Tables)
Operating Costs - Summary Of General And Administrative Expenses (Details)
Operating Costs - Summary Of Research And Development Expenditure (Details)
Operating Costs - Summary Of Research And Development Expenditure By Program (Details)
Operating Costs - Summary Of Sales And Marketing Expenses (Details)
Other Financial Income / Expenses
Other Financial Income / Expenses (Details)
Other Financial Income / Expenses (Tables)
Other Non-Current Assets
Other Non-Current Assets (Tables)
Other Non-Current Assets - Financial Assets Held At Fair Value Through Profit Or Loss (Details)
Other Non-Current Assets - Summary (Details)
Property, Plant And Equipment
Property, Plant And Equipment (Tables)
Property, Plant And Equipment - Carrying Amount (Details)
Property, Plant And Equipment - Fully Owned (Details)
Property, Plant And Equipment - Right Of Use (Details)
Related Parties
Related Parties (Tables)
Related Parties - Narrative (Details)
Related Parties - Summary Of Remuneration Package (Details)
Research And Development Incentives Receivables
Research And Development Incentives Receivables (Tables)
Research And Development Incentives Receivables - Current And Non-Current (Details)
Research And Development Incentives Receivables - Maturities (Details)
Segment Information
Segment Information (Details)
Segment Information (Tables)
Segment Information - Major Customers (Details)
Segment Information - Non-Current Assets By Location (Details)
Share Capital
Share Capital (Tables)
Share Capital - Capital Increase (Details)
Share Capital - History (Details)
Share Capital - History - Narrative (Details)
Share Capital - Other Information (Details)
Share Capital - Reconciliation (Details)
Significant Accounting Policies
Significant Accounting Policies (Details)
Significant Accounting Policies (Policies)
Significant Accounting Policies (Tables)
Significant Accounting Policies - Employee Benefits (Details)
Significant Accounting Policies - Impact Of Adoption Of Ifrs 15 (Details)
Significant Accounting Policies - Intangible Assets (Details)
Significant Accounting Policies - Property, Plant And Equipment (Details)
Significant Accounting Policies - Segment Reporting (Details)
Staff Costs
Staff Costs (Details)
Staff Costs (Tables)
Summary Of Significant Transaction
Summary Of Significant Transaction (Details)
Total Revenues And Other Income
Total Revenues And Other Income (Tables)
Total Revenues And Other Income - Allocation Of Transaction Price (Details)
Total Revenues And Other Income - Disaggregation Of Revenues (Details)
Total Revenues And Other Income - Recognition Of Payments (Details)
Total Revenues And Other Income - Summary Of Other Income (Details)
Trade And Other Liabilities
Trade And Other Liabilities (Details)
Trade And Other Liabilities (Tables)
Trade And Other Receivables And Other Current Assets
Trade And Other Receivables And Other Current Assets (Details)
Trade And Other Receivables And Other Current Assets (Tables)
Warrant Plans
Warrant Plans (Details)
Warrant Plans (Tables)
Warrant Plans - Category (Details)
Warrant Plans - Rollforward (Details)
Warrant Plans - Valuation (Details)
Ticker: GLPG
CIK: 1421876
Form Type: 20-F Annual Report
Accession Number: 0001558370-20-003270
Submitted to the SEC: Fri Mar 27 2020 4:41:43 PM EST
Accepted by the SEC: Fri Mar 27 2020
Period: Tuesday, December 31, 2019
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/glpg/0001558370-20-003270.htm